n-acetylneuraminic acid has been researched along with Obesity in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 7 (38.89) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 3 (16.67) | 2.80 |
Authors | Studies |
---|---|
Adam, M; Brandis, A; Cahalon, L; Clark, AR; Colaiuta, SP; Croese, T; Gold, O; Greka, A; Habib, N; Itkin, M; Kitsberg, D; Kohnert, E; Malitsky, S; Medina, S; Mehlman, T; Ravid, A; Salame, TM; Schwartz, M; Shapira, I; Slyper, M; Suzzi, S; Vernon, KA | 1 |
Kaburagi, T; Oshiro, S; Otsuka, Y | 1 |
Banerjee, S; Chambliss, KL; Chu, H; Kifer, D; Lauc, G; Mineo, C; Peng, J; Polasek, O; Rohatgi, A; Sacharidou, A; Shaul, PW; Sundgren, NC; Tanigaki, K; Vongpatanasin, W; Yuhanna, IS | 1 |
Aimaretti, G; Bicchi, C; Cialiè Rosso, M; Collino, M; Cordero, C; Liberto, E; Mai, S; Marzullo, P; Mele, C; Reichenbach, SE; Squara, S; Stilo, F | 1 |
Arıbaş, A; Çiçekler, H; Toker, A; Yerlikaya, FH | 1 |
Barbas, C; Bargiela, R; Cuervo, A; Ferrer, M; González, S; Hevia, A; López, P; Margolles, A; Martínez-Martínez, M; Milani, C; Moya, A; Rojo, D; Sánchez, B; Suárez, A; Ventura, M | 1 |
Abdullah, MA; Ideris, A; Imam, MU; Ismail, M; Ismail, N; Yida, Z | 1 |
Cen, C; Li, Y; Lu, Z; Ma, H; Shao, Z; Xu, C | 1 |
Aja, S; Aoki, K; Lei, X; Lopez, PH; Ronnett, GV; Schnaar, RL; Seldin, MM; Wong, GW | 1 |
Akin, L; Kendirci, M; Kurtoglu, S; Mazicioglu, M; Muhtaroğlu, S; Yikilmaz, A | 1 |
Browning, LM | 1 |
Browning, LM; Jebb, SA; Krebs, JD | 1 |
Akarsu, E; Aktaran, S; Kurtul, N | 1 |
Faur, L; Moldovan, C; Motocu, M; Muţiu, G; Onaca, M | 1 |
Browning, LM; Jebb, SA; Krebs, JD; Mishra, GD; Moore, CS; O'Connell, MA | 1 |
Dallar, Y; Savas Erdeve, S; Topkaya, BC; Yilmaz, FM; Yilmaz, G; Yücel, D | 1 |
Wakabayashi, I | 1 |
Abdella, N; Akanji, AO; Al Assoussi, A; Mojiminiyi, OA; Moussa, M | 1 |
1 review(s) available for n-acetylneuraminic acid and Obesity
Article | Year |
---|---|
n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease.
Topics: Anti-Inflammatory Agents; Cytokines; Fatty Acids, Omega-3; Humans; Inflammation; Inflammation Mediators; N-Acetylneuraminic Acid; Obesity | 2003 |
2 trial(s) available for n-acetylneuraminic acid and Obesity
Article | Year |
---|---|
Discrimination ratio analysis of inflammatory markers: implications for the study of inflammation in chronic disease.
Topics: Acute-Phase Proteins; Adult; Aged; Algorithms; Biomarkers; Body Mass Index; Body Weight; C-Reactive Protein; Chronic Disease; Cytokines; Female; Humans; Inflammation; Middle Aged; N-Acetylneuraminic Acid; Obesity | 2004 |
The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype.
Topics: Adult; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; N-Acetylneuraminic Acid; Obesity; Overweight; Phenotype; Treatment Outcome | 2007 |
15 other study(ies) available for n-acetylneuraminic acid and Obesity
Article | Year |
---|---|
N-acetylneuraminic acid links immune exhaustion and accelerated memory deficit in diet-induced obese Alzheimer's disease mouse model.
Topics: Alzheimer Disease; Animals; Diet, High-Fat; Disease Models, Animal; Humans; Memory Disorders; Mice; Mice, Transgenic; N-Acetylneuraminic Acid; Obesity | 2023 |
Antiobesity Effect of
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Anti-Obesity Agents; Antioxidants; Diet, High-Fat; Male; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Obesity; Plant Extracts | 2023 |
Supplementation With the Sialic Acid Precursor N-Acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.
Topics: Animals; Dietary Supplements; Endothelial Cells; Hexosamines; Hypertension; Immunoglobulin G; Male; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Obesity; Receptors, IgG | 2019 |
Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry.
Topics: Acetylglucosamine; Algorithms; Amino Acids, Neutral; Chromatography; Chromatography, Gas; Chromatography, High Pressure Liquid; Cyclohexanes; Deoxyribose; Esters; Fuzzy Logic; Gas Chromatography-Mass Spectrometry; Glucuronates; Humans; Lactose; Male; N-Acetylneuraminic Acid; Obesity; Reference Values; Saliva; Solvents; Spectrometry, Mass, Electrospray Ionization; Urea | 2021 |
The association of total sialic acid and malondialdehyde levels with metabolic and anthropometric variables in obesity.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Female; Humans; Insulin Resistance; Male; Malondialdehyde; Middle Aged; N-Acetylneuraminic Acid; Obesity; Risk Factors | 2015 |
Ranking the impact of human health disorders on gut metabolism: systemic lupus erythematosus and obesity as study cases.
Topics: Adult; Body Mass Index; Case-Control Studies; Female; Gastrointestinal Tract; Homeostasis; Humans; Lupus Erythematosus, Systemic; Metabolic Networks and Pathways; Metabolome; Metabolomics; Microbiota; Middle Aged; N-Acetylneuraminic Acid; Obesity | 2015 |
High fat diet-induced inflammation and oxidative stress are attenuated by N-acetylneuraminic acid in rats.
Topics: Animals; Biomarkers; Dietary Fats; Dietary Supplements; Hyperlipidemias; Liver; Male; N-Acetylneuraminic Acid; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2015 |
Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study.
Topics: Adult; Aged; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Metabolic Syndrome; Middle Aged; N-Acetylneuraminic Acid; Non-alcoholic Fatty Liver Disease; Obesity; Risk Factors | 2016 |
Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance.
Topics: Adipose Tissue; Animals; beta-Galactoside alpha-2,3-Sialyltransferase; Disease Models, Animal; Galactose; Gangliosides; Glucose Tolerance Test; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipid Metabolism; Mice; Mice, Knockout; N-Acetylneuraminic Acid; Obesity; Sialyltransferases | 2017 |
The association of serum sialic acid with carotid intima-media thickness and anthropometric and metabolic parameters in obese children and adolescents.
Topics: Adipose Tissue; Adolescent; Anthropometry; Atherosclerosis; Biomarkers; Blood Glucose; Carotid Intima-Media Thickness; Child; Cross-Sectional Studies; Female; Humans; Insulin; Insulin Resistance; Lipids; Male; Metabolic Syndrome; N-Acetylneuraminic Acid; Obesity; Risk Factors | 2011 |
The relationship between serum total sialic acid levels and adenosine deaminase activity in obesity.
Topics: Adenosine Deaminase; Adult; Female; Humans; Male; N-Acetylneuraminic Acid; Obesity | 2006 |
Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
Topics: Aged; Biomarkers; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Hyperlipidemias; Middle Aged; Myocardial Ischemia; N-Acetylneuraminic Acid; Obesity | 2005 |
Serum sialic acid, hs-CRP and oxidative stress parameters in obese children.
Topics: Atherosclerosis; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Case-Control Studies; Child; Cholesterol; Female; Humans; Male; Malondialdehyde; N-Acetylneuraminic Acid; Obesity; Oxidative Stress; Risk Factors; Sulfhydryl Compounds | 2007 |
Age-related change in relationship between body-mass index, serum sialic acid, and atherogenic risk factors.
Topics: Adult; Aging; Arteriosclerosis; Biomarkers; Blood Pressure; Body Mass Index; Cholesterol; Cholesterol, HDL; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Obesity; Regression Analysis; Risk Factors; Triglycerides; Uric Acid | 1998 |
Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
Topics: Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Electrocardiography; Female; Glycated Hemoglobin; Humans; Kuwait; Lipids; Male; N-Acetylneuraminic Acid; Obesity; Risk Factors; Sex Characteristics; Triglycerides | 2000 |